Rituximab -- a double-edged sword: can one treatment for thrombocytopenia also induce it?
Ram
Ron
R
Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel.
Raanani
Pia
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D010976:Platelet Count; D000069283:Rituximab; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab